Using comprehensive network pharmacology approaches, we identified three pivotal genes (c-Jun, ESR1, and MMP9) closely associated with HBV-related HCC pathogenesis and progression, including the highly bioactive compound bicuculline. The gene discussed is JUN; the disease is hepatocellular carcinoma.